Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression Psychedelics Investing
Lexston Mining Corporation Announces Incorporation of Wholly Owned Subsidiary Lexston Guyana Inc. Life Science Investing
US FDA Has Granted A "Rare Pediatric Disease Drug" Designation for NV-387 As A Treatment for Measles - Enables Priority Review Voucher Life Science Investing
Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central Africa Life Science Investing
Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit Life Science Investing
Cizzle Brands Corporation Celebrates Gavin McKenna's First Overall Draft Selection with the Launch of Limited-Edition CWENCH "Draft Day Blue" Biotech Investing
Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results Medical Device Investing
Palvella Therapeutics Submits First Module of Rolling New Drug Application to FDA for QTORIN Rapamycin for the Treatment of Microcystic Lymphatic Malformations Life Science Investing
Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer Life Science Investing
